Ann: ATL1102 Early Access Program for Patients with MS, page-28

So we could be selling our drug for MS in the USA in 2015
Akki...my tomorrow is run by experts...Where does that leave you,when they are willing to put up the $$$$


About myTomorrows

myTomorrows was founded by physicians and experts from the pharmaceutical industry who want to facilitate early access to the latest drug innovations for patients with high unmet needs, who are excluded from clinical trials.
A newspaper article quote from an ALS patient needing access to not-yet-registered drugs was the inspiration for the company’s name: “I just want some more tomorrows”.
myTomorrows was launched in April 2013, and operates in a growing number of European countries and will expand to the US in 2015.

Our motivation

Imagine. One of your relatives or friends is seriously ill and cannot be treated with available drugs. Some of the founders have been through this ordeal.
Seriously ill patients are increasingly aware of the latest drug developments in their disease area. Sometimes patients can participate in clinical trials, but more often they cannot.
For these patients and their physicians, myTomorrows is building a bridge to drug developers.
Meet our team
"When my father had no more treatment options and was dying of lung cancer I could have given him access to promising unapproved therapies because I worked in the biotech industry. When he passed away I realised how unfair it was that only I had that option. That’s why I founded myTomorrows."
− Ronald Brus MD